Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Kanakry

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Transfusion|December 21, 2012
Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose schedulingJennifer A Kanakry, Douglas E Gladstone
Current Treatment Options in Oncology|April 4, 2013
EBV-related lymphomas: new approaches to treatmentJennifer A Kanakry, Richard F Ambinder
Case Reports in Hepatology|August 22, 2025
Autoimmune-Like Hepatitis Following Hepatic Graft-Versus-Host Disease in an Allogenic Hematopoietic Cell Transplant RecipientHarish Gopalakrishna, David E Kleiner, Jennifer A Kanakry, et al.
Transfusion|April 26, 2021
Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case reportSajjad Hassan, Kamille A West, William W Ward, et al.
Journal of Clinical Immunology|July 23, 2020
Successful Matched Related Bone Marrow Transplantation in a Patient with Autosomal Dominant Interferon Gamma Receptor 1 DeficiencyChrista S Zerbe, Dimana Dimitrova, Juan J Gea-Banacloche, et al.
Cancers|February 15, 2022
Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell LeukemiasElisaveta Voynova, Nga Hawk, Francis A Flomerfelt, et al.
Blood|January 9, 2016
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseasesJennifer A Kanakry, Aparna M Hegde, Christine M Durand, et al.
Transplantation and Cellular Therapy|May 16, 2025
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide ProphylaxisRohtesh S Mehta, Yosra M Aljawai, Taha Al-Juhaishi, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2024
IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypesNatchanun Klangkalya, Jennifer Stoddard, Julie Niemela, et al.
Blood Advances|July 12, 2022
Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamideMichael T Patterson, Natalia S Nunes, Lucas P Wachsmuth, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Transfusion|December 21, 2012
Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose schedulingJennifer A Kanakry, Douglas E Gladstone
Current Treatment Options in Oncology|April 4, 2013
EBV-related lymphomas: new approaches to treatmentJennifer A Kanakry, Richard F Ambinder
Case Reports in Hepatology|August 22, 2025
Autoimmune-Like Hepatitis Following Hepatic Graft-Versus-Host Disease in an Allogenic Hematopoietic Cell Transplant RecipientHarish Gopalakrishna, David E Kleiner, Jennifer A Kanakry, et al.
Transfusion|April 26, 2021
Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case reportSajjad Hassan, Kamille A West, William W Ward, et al.
Journal of Clinical Immunology|July 23, 2020
Successful Matched Related Bone Marrow Transplantation in a Patient with Autosomal Dominant Interferon Gamma Receptor 1 DeficiencyChrista S Zerbe, Dimana Dimitrova, Juan J Gea-Banacloche, et al.
Cancers|February 15, 2022
Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell LeukemiasElisaveta Voynova, Nga Hawk, Francis A Flomerfelt, et al.
Blood|January 9, 2016
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseasesJennifer A Kanakry, Aparna M Hegde, Christine M Durand, et al.
Transplantation and Cellular Therapy|May 16, 2025
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide ProphylaxisRohtesh S Mehta, Yosra M Aljawai, Taha Al-Juhaishi, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2024
IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypesNatchanun Klangkalya, Jennifer Stoddard, Julie Niemela, et al.
Blood Advances|July 12, 2022
Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamideMichael T Patterson, Natalia S Nunes, Lucas P Wachsmuth, et al.
Pageof 6